Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
20 Dec 2022
// Gabrielle Masson FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/pfizer-puts-20m-rights-lianbio-rsv-program-greater-china
10 Jun 2022
// CPI
https://www.competitionpolicyinternational.com/pfizer-completes-acquisition-of-reviral/
08 Apr 2022
// K. Jensen BIOPHARMADIVE
https://www.biopharmadive.com/news/pfizer-rsv-reviral-acquisition-virus-drug/621751/
17 Jan 2022
// BUSINESSWIRE
17 Jun 2021
// CLINICAL TRAILS ARENA
https://www.clinicaltrialsarena.com/news/reviral-paediatric-trial-sisunatovir/
16 Jun 2021
// BUSINESSWIRE
https://www.businesswire.com/news/home/20210616005103/en/ReViral-Announces-Positive-Recommendation-by-the-Data-Safety-Monitoring-Committee-to-Continue-the-Phase-2-Clinical-Study-of-Sisunatovir-for-Treatment-of-Respiratory-Syncytial-Virus-Infections-in-Hospitalized-Infants
ABOUT THIS PAGE